ScholarIQanswers from OpenAlex & ORCID
Sonja Levy
ResearcherPublications, citations & collaboration network
Sonja Levy is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sonja Levy have?
ScholarIQindexed works
Sonja Levy has 21 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sonja Levy have?
ScholarIQcitation count
Sonja Levy has 239 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sonja Levy?
ScholarIQh-index
Sonja Levy has an h-index of 8 in OpenAlex.
What is the i10-index of Sonja Levy?
ScholarIQi10-index
Sonja Levy has an i10-index of 8 in OpenAlex.
What is the ORCID of Sonja Levy?
ScholarIQorcid
The ORCID for Sonja Levy is on the source record.
What is the OpenAlex record for Sonja Levy?
ScholarIQopenalex
The OpenAlex for Sonja Levy is on the source record.
What are the most-cited papers on Sonja Levy?
ScholarIQmost cited works
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Talya L. Dayton, Nicolas Alcala, Laura Moonen, Lisanne den Hartigh, Veerle Geurts, Lise Mangiante, L. Lap, Antonella F. M. Dost, Joep Beumer, Sonja Levy, Rachel S. van Leeuwaarde, Wenzel M. Hackeng, Kris G. Samsom, Catherine Voegele, Alexandra Sexton‐Oates, Harry Begthel, Jeroen Korving, Lisa M. Hillen, Lodewijk A.A. Brosens, Sylvie Lantuéjoul, Sridevi Jaksani, Niels F.M. Kok, Koen J. Hartemink, Houke M. Klomp, Inne H.M. Borel Rinkes, Anne‐Marie C. Dingemans, Gerlof D. Valk, Menno R. Vriens, Wieneke A. Buikhuisen, José van den Berg, Margot Tesselaar, Jules L. Derks, Ernst‐Jan M. Speel, Matthieu Foll, Lynnette Fernandez‐Cuesta, Hans Clevers
Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
Sonja Levy, Maureen J.B. Aarts, Ferry A.L.M. Eskens, Kristien Keymeulen, Lukas B. Been, Dirk J. Grünhagen, Alexander C. J. van Akkooi, Mathilde Jalving, Margot Tesselaar
Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours
Kris G. Samsom, Sonja Levy, Linde M. van Veenendaal, Paul Roepman, Liudmila L. Kodach, Neeltje Steeghs, Gerlof D. Valk, M. W. Dercksen, Koert F.D. Kuhlmann, Wieke H.M. Verbeek, Gerrit A. Meijer, Margot Tesselaar, José G. van den Berg
Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
Sonja Levy, Linde M. van Veenendaal, Catharina M. Korse, Emilie C. H. Breekveldt, Wieke H.M. Verbeek, Menno R. Vriens, Koert F.D. Kuhlmann, José G. van den Berg, Gerlof D. Valk, Margot Tesselaar
Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response
Lisanne P. Zijlker, Sonja Levy, W. Wolters, Johannes V. van Thienen, Alexander C. J. van Akkooi, Margot Tesselaar